
Mohan Elango
I am worked as Sr. CRA for Novo Nordisk thru Syneos Health. I am worked as CTPS for... | Le Petit-Canada, Le Petit-Canada, Canada
*50 free lookup(s) per month.
No credit card required.
Mohan Elango’s Emails mo****@jn****.com
Mohan Elango’s Phone Numbers No phone number available.
Social Media
Mohan Elango’s Location Le Petit-Canada, Le Petit-Canada, Canada
Mohan Elango’s Expertise I am worked as Sr. CRA for Novo Nordisk thru Syneos Health. I am worked as CTPS for Bayer thru Brunnel Canada. u2022 Lead the team for assessing and submitting SUSAR reports from Clinical trials Phase I and Phase III (Oncology trials for Biologics) to the regulatory authorities and Ethics committee u2022 Managed and lead the team for writing Safety management plan (SMMP) for Phase III Oncology based trial (Breast cancer studies) u2022 Lead the team for medical review of Individual case reports (ICSRu2019s) for the SUSARu2019S received from clinical trials u2022 Lead the team for developing the annual submission of Developmental safety update (DSUR) reports for the Phase I and Phase III clinical trial SAEu2019s and SARu2019s u2022 Lead the team for quality compliance related to the accuracy, consistency and data reconciliation for the SAEu2019s and SARu2019s from clinical trials and post-marketed ICSRu2019s u2022 Lead the team for the Risk Management Plan (RMP) on the new safety signal detected from clinical trials and marketed products u2022 Lead the team for writing work instructions (WI) and Standard operating procedures for clinical trials u2022 Managed quality review on serious (SAEu2019s) and non-serious adverse events (AE) and assessed seriousness, expectedness of ICSR's from all sources for post-marketing spontaneous, literature, regulatory and Non-interventional study reports u2022 Drafted and managed regulatory submission of periodic safety update reports (PSURs) for EMEA, periodic adverse experience reports (PADER)for US FDA and Canadian annual summary reports(CAR) for Health Canada u2022 Performed signal detection and evaluated the new signal based on ICSRu2019s in the Safety database u2022 Presented the safety issues to the drug safety committee and updated the core safety data profile for the marketed products.
Mohan Elango’s Current Industry Novo Nordisk
Mohan
Elango’s Prior Industry
Apotex Inc.
|
Johnson & Johnson
|
NoNO Inc
|
Purdue Pharma (Canada)
|
Bayer
|
Novo Nordisk
Not the Mohan Elango you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Novo Nordisk
Sr. CRA
Mon Jan 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Bayer
CTPS
Thu Jun 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Purdue Pharma (Canada)
Sr.CRA
Mon Aug 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Apr 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
NoNO Inc
Lead CRA
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Aug 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Johnson & Johnson
Risk Management Associate-CT & DS
Fri Nov 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Apotex Inc.
Drug safety associate
Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)